SIRT1 and Insulin resistance: Overall, these strategies illustrate how the administration of NAD+ precursors constitutes an excellent tool to enhance SIRT1 activity in vivo and recapitulate the health benefits of SIRT1 overexpression, e.g. a strong protection against insulin resistance and increased oxidative capacity.